Nicolás Nagy

Nicolás Nagy

CEO, IN VITRO S.L. | Finance, Strategy & Business Continuity

With more than 19 years of international experience across Europe and Latin America, Nicolas Nagy brings a strong background in finance, corporate strategy, investment, and business growth to IN VITRO S.L. His career combines the discipline and execution standards of major multinational corporations with the agility and entrepreneurial mindset required to build and scale growing businesses. Nicolas joined IN VITRO S.L. as CEO following its generational transition, with a clear mission: to apply his corporate and financial experience to a company with 40 years of scientific know-how in plant biotechnology and tissue culture, ensuring its business continuity while preparing it for its next stage of development. His role focuses on strengthening the company's financial structure, corporate governance, operational performance, and strategic planning, while creating the conditions for sustainable international growth. Working closely with the scientific and production teams, he helps connect IN VITRO's laboratory expertise with the commercial and financial requirements of a modern biotechnology business. A particular focus is the development of Paulownia 112®, transforming decades of expertise in micropropagation and plant genetics into a scalable international business opportunity across forestry, agroforestry, and land-regeneration projects. Throughout his career, Nicolas has led cross-functional teams, developed growth strategies, and successfully managed financing processes involving banks, private equity, and direct investments, including seven-figure transactions. At IN VITRO, his objective is clear: protect the company's scientific legacy, guarantee its long-term business continuity, and build the financial and organizational foundations required for the next generation of growth.

LinkedIn profile5 articles